Published in Cell Physiol Biochem on August 03, 2009
Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol (2010) 1.53
Ceramide-rich platforms in transmembrane signaling. FEBS Lett (2010) 1.46
Sphingolipid signaling in metabolic disorders. Cell Metab (2012) 1.37
Kdo2-lipid A, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264.7 macrophages, which is essential for induction of autophagy. J Biol Chem (2010) 1.29
DC-SIGN mediated sphingomyelinase-activation and ceramide generation is essential for enhancement of viral uptake in dendritic cells. PLoS Pathog (2011) 1.00
Regulation of protein kinases by lipids. Curr Opin Struct Biol (2011) 0.99
It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation. Neurochem Res (2012) 0.94
Membrane signaling induced by high doses of ionizing radiation in the endothelial compartment. Relevance in radiation toxicity. Int J Mol Sci (2013) 0.93
Ceramide in stem cell differentiation and embryo development: novel functions of a topological cell-signaling lipid and the concept of ceramide compartments. J Lipids (2010) 0.86
Sphingolipids in neurodegeneration. Neuromolecular Med (2010) 0.85
KSR1 is a functional protein kinase capable of serine autophosphorylation and direct phosphorylation of MEK1. Exp Cell Res (2010) 0.84
Re-configuration of sphingolipid metabolism by oncogenic transformation. Biomolecules (2014) 0.83
Kinase suppressor of Ras transphosphorylates c-Raf-1. Biochem Biophys Res Commun (2009) 0.82
Two protein kinase C isoforms, δ and ε, regulate energy homeostasis in mitochondria by transmitting opposing signals to the pyruvate dehydrogenase complex. FASEB J (2012) 0.80
Proteome-wide Identification of Novel Ceramide-binding Proteins by Yeast Surface cDNA Display and Deep Sequencing. Mol Cell Proteomics (2016) 0.76
Laurdan monitors different lipids content in eukaryotic membrane during embryonic neural development. Cell Biochem Biophys (2014) 0.76
Roles for biological membranes in regulating human immunodeficiency virus replication and progress in the development of HIV therapeutics that target lipid metabolism. J Neuroimmune Pharmacol (2011) 0.75
Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat Cell Biol (1999) 4.94
GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat Cell Biol (2001) 4.42
RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat Immunol (2000) 4.28
KSR, a novel protein kinase required for RAS signal transduction. Cell (1995) 3.27
Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem (1991) 3.20
Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester. Cell (1995) 3.08
Specific binding of phorbol ester tumor promoters. Proc Natl Acad Sci U S A (1980) 3.07
Phorbol ester binding to protein kinase C requires a cysteine-rich zinc-finger-like sequence. Proc Natl Acad Sci U S A (1989) 2.72
The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell (1996) 2.66
The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans. Cell (1995) 2.65
Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem (1996) 2.58
Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol Cell Biol (2002) 2.54
KSR modulates signal propagation within the MAPK cascade. Genes Dev (1996) 2.46
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat Cell Biol (2005) 2.41
PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J (1995) 2.14
Kinase suppressor of Ras is ceramide-activated protein kinase. Cell (1997) 2.05
Taxonomy and function of C1 protein kinase C homology domains. Protein Sci (1997) 1.98
C1 domains exposed: from diacylglycerol binding to protein-protein interactions. Biochim Biophys Acta (2006) 1.98
KSR: a MAPK scaffold of the Ras pathway? J Cell Sci (2001) 1.90
The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells. Mol Cell Biol (2004) 1.86
Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol (2003) 1.81
KSR stimulates Raf-1 activity in a kinase-independent manner. Proc Natl Acad Sci U S A (1997) 1.72
Novel "nonkinase" phorbol ester receptors: the C1 domain connection. Mol Pharmacol (2002) 1.66
Competitive inhibition by diacylglycerol of specific phorbol ester binding. Proc Natl Acad Sci U S A (1984) 1.60
Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. Cancer Res (2003) 1.60
Direct binding to ceramide activates protein kinase Czeta before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells. J Biol Chem (2005) 1.57
Caveolae purification and glycosylphosphatidylinositol-linked protein sorting in polarized epithelia. Methods Enzymol (1995) 1.54
Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. J Biol Chem (2007) 1.52
Lambda-interacting protein, a novel protein that specifically interacts with the zinc finger domain of the atypical protein kinase C isotype lambda/iota and stimulates its kinase activity in vitro and in vivo. Mol Cell Biol (1996) 1.51
Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation. J Biol Chem (1994) 1.37
Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci U S A (1996) 1.34
Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation. J Biol Chem (2004) 1.31
Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol Cell Biol (1994) 1.27
Solution structure of a cysteine rich domain of rat protein kinase C. Nat Struct Biol (1994) 1.25
A Ras-mediated signal transduction pathway is involved in the control of sex myoblast migration in Caenorhabditis elegans. Development (1996) 1.23
Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide. Biochem J (2008) 1.22
Molecular mechanisms of ceramide-mediated CD95 clustering. Biochem Biophys Res Commun (2001) 1.17
Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR). J Mol Biol (2002) 1.14
A novel diacylglycerol-lactone shows marked selectivity in vitro among C1 domains of protein kinase C (PKC) isoforms alpha and delta as well as selectivity for RasGRP compared with PKCalpha. J Biol Chem (2005) 1.13
Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer. Nat Med (2003) 1.12
Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling. EMBO J (1998) 1.07
Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton. J Cell Sci (2004) 1.02
Associations of B- and C-Raf with cholesterol, phosphatidylserine, and lipid second messengers: preferential binding of Raf to artificial lipid rafts. J Biol Chem (2002) 1.00
KSR: a novel player in the RAS pathway. Cell (1995) 1.00
Retracted Kinase suppressor of Ras signals through Thr269 of c-Raf-1. J Biol Chem (2000) 0.99
The regulatory domain of protein kinase C coordinates four atoms of zinc. J Biol Chem (1992) 0.97
Epidermal growth factor treatment enhances the kinase activity of kinase suppressor of Ras. J Biol Chem (2000) 0.97
The requirement of specific membrane domains for Raf-1 phosphorylation and activation. J Biol Chem (2002) 0.90
Hypothesis: ceramide conditionally activates atypical protein kinases C, Raf-1 and KSR through binding to their cysteine-rich domains. Biochem J (1998) 0.87
Selective localization of recognition complexes for leukotriene B4 and formyl-Met-Leu-Phe within lipid raft microdomains of human polymorphonuclear neutrophils. J Immunol (2006) 0.87
Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science (2003) 7.86
High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys (2008) 3.78
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J Clin Oncol (2010) 3.76
Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity (2012) 2.99
Radiation and ceramide-induced apoptosis. Oncogene (2003) 2.68
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys (2002) 2.65
Crypt base columnar stem cells in small intestines of mice are radioresistant. Gastroenterology (2012) 2.31
Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. J Urol (2008) 2.30
ATM regulates target switching to escalating doses of radiation in the intestines. Nat Med (2005) 2.28
Raft ceramide in molecular medicine. Oncogene (2003) 2.20
Engaging the vascular component of the tumor response. Cancer Cell (2005) 2.05
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. J Clin Invest (2011) 1.97
Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett (2002) 1.86
Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation. PLoS One (2011) 1.86
Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys (2008) 1.85
Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans. Science (2008) 1.83
Sphingolipids and cell death. Apoptosis (2007) 1.71
Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease. Blood (2009) 1.67
Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2002) 1.67
Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal (2010) 1.60
Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. Cancer Res (2003) 1.60
Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys (2007) 1.54
Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene (2003) 1.53
The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2. J Biol Chem (2002) 1.52
Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol (2003) 1.51
CD95 rapidly clusters in cells of diverse origins. Cancer Biol Ther (2003) 1.50
PKCalpha activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo. Cancer Biol Ther (2009) 1.48
Ceramide-rich platforms in transmembrane signaling. FEBS Lett (2010) 1.46
Caspase-dependent and -independent activation of acid sphingomyelinase signaling. J Biol Chem (2005) 1.44
Bax and Bak do not exhibit functional redundancy in mediating radiation-induced endothelial apoptosis in the intestinal mucosa. Int J Radiat Oncol Biol Phys (2008) 1.34
Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res (2003) 1.33
Microvascular function regulates intestinal crypt response to radiation. Cancer Res (2003) 1.30
Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation. Nat Genet (2004) 1.29
Kinetic characterization of mammalian ceramide synthases: determination of K(m) values towards sphinganine. FEBS Lett (2007) 1.29
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol (2003) 1.27
Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes. Genomics (2002) 1.22
Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys (2011) 1.16
Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway. Autophagy (2009) 1.16
Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice. J Clin Invest (2012) 1.15
Health status, work limitations, and return-to-work trajectories in injured workers with musculoskeletal disorders. Qual Life Res (2007) 1.14
Accurate setup of paraspinal patients using a noninvasive patient immobilization cradle and portal imaging. Med Phys (2005) 1.13
Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery. PLoS One (2010) 1.13
Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys (2010) 1.13
Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer. Nat Med (2003) 1.12
Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat Med (2002) 1.12
Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.12
From IMRT to IGRT: frontierland or neverland? Radiother Oncol (2006) 1.11
IMRT of large fields: whole-abdomen irradiation. Int J Radiat Oncol Biol Phys (2002) 1.09
Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. Am J Physiol Cell Physiol (2010) 1.09
Intensity-modulated radiotherapy. Cancer J (2002) 1.07
Sphingosine-1-phosphate activates the AKT pathway to protect small intestines from radiation-induced endothelial apoptosis. Cancer Res (2010) 1.07
Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities. J Med Chem (2008) 1.04
Down-regulation of ATM protein sensitizes human prostate cancer cells to radiation-induced apoptosis. J Biol Chem (2005) 1.03
Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol (2002) 1.02
Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited. Cancer Res (2010) 1.01
Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol (2003) 1.00
Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. Radiother Oncol (2002) 1.00
The Readiness for Return-To-Work (RRTW) scale: development and validation of a self-report staging scale in lost-time claimants with musculoskeletal disorders. J Occup Rehabil (2007) 0.99
Involvement of membrane signaling in the bystander effect in irradiated cells. Cancer Res (2002) 0.99
Acid sphingomyelinase-derived ceramide signaling in apoptosis. Subcell Biochem (2002) 0.97